Our Partners

Bio<sup>M</sup> Community Network

BioM Community Network

Your contact

Dr. Andreas Berghammer

Community Services & Business Strategy Lead


4SC AG

4SC is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical need.
4SC&#039;s pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development: resminostat.
4SC had 46 employees as of 31 December 2021 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A3E5C4).
Categories: Biotech Therapeutics &amp; Diagnostics
Fraunhoferstraße 22
Deutschland-82152 Planegg-Martinsried
Telephone: +49 (0) 89 700763-0
Fax: +49 (0) 89 700763-29